Xuejun Hu

1.7k total citations
62 papers, 1.2k citations indexed

About

Xuejun Hu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xuejun Hu has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 23 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Xuejun Hu's work include Lung Cancer Treatments and Mutations (12 papers), Cancer-related molecular mechanisms research (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Xuejun Hu is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer-related molecular mechanisms research (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Xuejun Hu collaborates with scholars based in China, United States and Japan. Xuejun Hu's co-authors include Xiujuan Qu, Yunpeng Liu, Kezuo Hou, Ye Zhang, Ling Xu, Xiaofang Che, Yuee Teng, Jing Liu, Jingdong Zhang and Jinglei Qu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Xuejun Hu

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuejun Hu China 22 762 373 331 259 153 62 1.2k
Uma Giri United States 23 984 1.3× 472 1.3× 489 1.5× 263 1.0× 126 0.8× 51 1.6k
Shilpa Kuttikrishnan Qatar 21 781 1.0× 257 0.7× 240 0.7× 85 0.3× 111 0.7× 46 1.2k
Jihong Feng China 20 696 0.9× 346 0.9× 333 1.0× 207 0.8× 140 0.9× 49 1.2k
Zhao‐Yang Lu China 23 779 1.0× 439 1.2× 387 1.2× 89 0.3× 366 2.4× 64 1.7k
Malihe Hasanzadeh Iran 19 654 0.9× 375 1.0× 389 1.2× 154 0.6× 138 0.9× 77 1.5k
Takafumi Nishimura Japan 21 823 1.1× 639 1.7× 286 0.9× 269 1.0× 97 0.6× 51 1.8k
Anitha Shenoy India 17 544 0.7× 276 0.7× 198 0.6× 102 0.4× 92 0.6× 44 945
Zheng Zhu China 20 834 1.1× 440 1.2× 577 1.7× 378 1.5× 57 0.4× 41 1.6k
Xiaofang Yi China 21 740 1.0× 202 0.5× 355 1.1× 208 0.8× 143 0.9× 67 1.4k
Bibo Tan China 22 790 1.0× 255 0.7× 558 1.7× 290 1.1× 160 1.0× 103 1.4k

Countries citing papers authored by Xuejun Hu

Since Specialization
Citations

This map shows the geographic impact of Xuejun Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejun Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejun Hu more than expected).

Fields of papers citing papers by Xuejun Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuejun Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejun Hu. The network helps show where Xuejun Hu may publish in the future.

Co-authorship network of co-authors of Xuejun Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuejun Hu. A scholar is included among the top collaborators of Xuejun Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejun Hu. Xuejun Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xuejun, et al.. (2025). Collaborative Buffer Monitoring and Control of Critical Chain Multi-Projects Considering Cross-Level Risk-Sharing Effect. Asia Pacific Journal of Operational Research. 43(1). 1 indexed citations
2.
Liu, Yuhang, Ning Ding, Qian Wang, et al.. (2022). Highly Expressed Soluble Recombinant Anti-GFP VHHs in Escherichia coli via Optimized Signal Peptides, Strains, and Inducers. Frontiers in Molecular Biosciences. 9. 848829–848829. 8 indexed citations
3.
4.
Wang, Yizhe, Chunlei Zheng, Wenqing Lü, et al.. (2021). Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer. Frontiers in Oncology. 11. 620154–620154.
5.
Wang, Shuo, Xiujuan Qu, Lili Cao, et al.. (2020). <p>Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung Cancer</p>. Cancer Management and Research. Volume 12. 4029–4038. 6 indexed citations
6.
Yang, Chen, Jie Wu, Cheng Yang, et al.. (2020). Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2. Pharmacological Research. 159. 105007–105007. 24 indexed citations
7.
Deng, Mingming, Zhe Zhang, Bofang Liu, et al.. (2020). Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis. Frontiers in Oncology. 10. 227–227. 10 indexed citations
8.
Xu, Ling, Xiujuan Qu, Xuejun Hu, et al.. (2018). β‐elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts. Cell Biology International. 42(10). 1377–1385. 19 indexed citations
9.
Liu, Chang, Zhi Li, Shuo Wang, et al.. (2018). FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 145(1). 65–76. 17 indexed citations
10.
Deng, Mingming, Ruoxi Yu, Shuo Wang, et al.. (2018). Limb-Bud and Heart Attenuates Growth and Invasion of Human Lung Adenocarcinoma Cells and Predicts Survival Outcome. Cellular Physiology and Biochemistry. 47(1). 223–234. 25 indexed citations
11.
Ma, Rui, Ling Xu, Xiujuan Qu, et al.. (2018). AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status. British Journal of Cancer. 118(11). 1453–1463. 12 indexed citations
12.
Zhang, Ye, Xiujuan Qu, Xiaofang Che, et al.. (2017). miR‐200a enhances TRAIL‐induced apoptosis in gastric cancer cells by targeting A20. Cell Biology International. 42(5). 506–514. 24 indexed citations
13.
Hou, Gang, et al.. (2014). Efficacy of real-time polymerase chain reaction for rapid diagnosis of endobronchial tuberculosis. International Journal of Infectious Diseases. 27. 13–17. 5 indexed citations
14.
Zeng, Dan, et al.. (2013). CD14 regulates gastric cancer cell epithelial-mesenchymal transition and invasion in vitro. Oncology Reports. 30(6). 2725–2732. 18 indexed citations
15.
Li, Kang, et al.. (2013). CD14 overexpression upregulates TNF-α-mediated inflammatory responses and suppresses the malignancy of gastric carcinoma cells. Molecular and Cellular Biochemistry. 376(1-2). 137–143. 6 indexed citations
16.
Xu, Ling, Ye Zhang, Jing Liu, et al.. (2012). TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells. European Journal of Cancer. 48(17). 3288–3299. 47 indexed citations
17.
18.
Xu, Ling, Xiujuan Qu, Ye Zhang, et al.. (2009). Oxaliplatin enhances TRAIL‐induced apoptosis in gastric cancer cells by CBL‐regulated death receptor redistribution in lipid rafts. FEBS Letters. 583(5). 943–948. 64 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uma Giri Breakdown of academic impact, for papers by Shilpa Kuttikrishnan Breakdown of academic impact, for papers by Jihong Feng Breakdown of academic impact, for papers by Zhao‐Yang Lu Breakdown of academic impact, for papers by Malihe Hasanzadeh Breakdown of academic impact, for papers by Takafumi Nishimura Breakdown of academic impact, for papers by Anitha Shenoy Breakdown of academic impact, for papers by Zheng Zhu Breakdown of academic impact, for papers by Xiaofang Yi Breakdown of academic impact, for papers by Bibo Tan
Rankless by CCL
2026